21 | | - | service for certain Medicaid recipients; requiring the 8 |
---|
22 | | - | agency to adopt rules; providing an effective date. 9 |
---|
23 | | - | 10 |
---|
24 | | - | Be It Enacted by the Legislature of the State of Florida: 11 |
---|
25 | | - | 12 |
---|
26 | | - | Section 1. Section 409.9063, Florida Statutes, is created 13 |
---|
27 | | - | to read: 14 |
---|
28 | | - | 409.9063 Rapid whole genome sequencing services for 15 |
---|
29 | | - | Medicaid recipients. — 16 |
---|
30 | | - | (1) As used in this section, the term "rapi d whole genome 17 |
---|
31 | | - | sequencing" means an investigation of the entire human genome, 18 |
---|
32 | | - | including coding and noncoding regions and mitochondrial 19 |
---|
33 | | - | deoxyribonucleic acid, to identify disease -causing genetic 20 |
---|
34 | | - | changes which yields preliminary results within 5 days and the 21 |
---|
35 | | - | final results within 14 days. The term includes patient -only 22 |
---|
36 | | - | whole genome sequencing and duo and trio whole genome sequencing 23 |
---|
37 | | - | of the patient and biological parent or parents. 24 |
---|
38 | | - | (2) Subject to any required approval of the Centers for 25 |
---|
| 21 | + | service for certain Medicaid recipients; requiring 8 |
---|
| 22 | + | that genetic data generated as a result of the rapid 9 |
---|
| 23 | + | whole genome sequencing be used only for specified 10 |
---|
| 24 | + | purposes; providing for the use of such data in 11 |
---|
| 25 | + | scientific research if the patient or his or her legal 12 |
---|
| 26 | + | guardian provides express consent for that use; 13 |
---|
| 27 | + | providing for the rescission of such consent; 14 |
---|
| 28 | + | requiring the entities conducting the scientific 15 |
---|
| 29 | + | research, upon receipt of a written revocation of 16 |
---|
| 30 | + | consent, to cease use of the patient's data and 17 |
---|
| 31 | + | expunge it from any data repositories where it is 18 |
---|
| 32 | + | held; requiring the agency to seek federal approval to 19 |
---|
| 33 | + | amend current waivers, request a new waiver, and amend 20 |
---|
| 34 | + | contracts as necessary for a specified purpose; 21 |
---|
| 35 | + | requiring the agency to adopt rules; providing an 22 |
---|
| 36 | + | effective date. 23 |
---|
| 37 | + | 24 |
---|
| 38 | + | Be It Enacted by the Legislature of the State of Florida: 25 |
---|
51 | | - | Medicare and Medicaid Services, the agency shall include 26 |
---|
52 | | - | coverage of rapid whole genome sequencing as a separately 27 |
---|
53 | | - | payable service for a Medicaid recipient who: 28 |
---|
54 | | - | (a) Is 20 years of age or younger; 29 |
---|
55 | | - | (b) Has a complex or acute illness of unknown etiology 30 |
---|
56 | | - | which is confirmed not to have been caused by an environmental 31 |
---|
57 | | - | exposure, a toxic ingestion, an infection with normal response 32 |
---|
58 | | - | to therapy, or trauma; and 33 |
---|
59 | | - | (c) Is receiving inpatient hospital services in an 34 |
---|
60 | | - | intensive care unit or a high -acuity pediatric care unit. 35 |
---|
61 | | - | (3) The agency shall adopt rules to implement this 36 |
---|
62 | | - | section. 37 |
---|
63 | | - | Section 2. This act shall take effect July 1, 2023. 38 |
---|
| 51 | + | 26 |
---|
| 52 | + | Section 1. Section 409.9063, Flori da Statutes, is created 27 |
---|
| 53 | + | to read: 28 |
---|
| 54 | + | 409.9063 Rapid whole genome sequencing services for 29 |
---|
| 55 | + | Medicaid recipients. — 30 |
---|
| 56 | + | (1) As used in this section, the term "rapid whole genome 31 |
---|
| 57 | + | sequencing" means an investigation of the entire human genome, 32 |
---|
| 58 | + | including coding and non coding regions and mitochondrial 33 |
---|
| 59 | + | deoxyribonucleic acid, to identify disease -causing genetic 34 |
---|
| 60 | + | changes which yields preliminary results within 5 days and the 35 |
---|
| 61 | + | final results within 14 days. The term includes patient -only 36 |
---|
| 62 | + | whole genome sequencing and duo and trio whole genome sequencing 37 |
---|
| 63 | + | of the patient and biological parent or parents. 38 |
---|
| 64 | + | (2) Subject to any required approval of the Centers for 39 |
---|
| 65 | + | Medicare and Medicaid Services, the agency shall include 40 |
---|
| 66 | + | coverage of rapid whole genome sequencing as a separately 41 |
---|
| 67 | + | payable service for a Medicaid recipient who: 42 |
---|
| 68 | + | (a) Is 20 years of age or younger; 43 |
---|
| 69 | + | (b) Has a complex or acute illness of unknown etiology 44 |
---|
| 70 | + | which is confirmed not to have been caused by an environmental 45 |
---|
| 71 | + | exposure, a toxic ingestion, an infection with normal response 46 |
---|
| 72 | + | to therapy, or trauma; and 47 |
---|
| 73 | + | (c) Is receiving inpatient hospital services in an 48 |
---|
| 74 | + | intensive care unit or a high -acuity pediatric care unit. 49 |
---|
| 75 | + | (3)(a) Except as specified in paragraph (b), genetic data 50 |
---|
| 76 | + | |
---|
| 77 | + | CS/HB 1043 2023 |
---|
| 78 | + | |
---|
| 79 | + | |
---|
| 80 | + | |
---|
| 81 | + | CODING: Words stricken are deletions; words underlined are additions. |
---|
| 82 | + | hb1043-01-c1 |
---|
| 83 | + | Page 3 of 3 |
---|
| 84 | + | F L O R I D A H O U S E O F R E P R E S E N T A T I V E S |
---|
| 85 | + | |
---|
| 86 | + | |
---|
| 87 | + | |
---|
| 88 | + | generated as a result of performing rapid whole genome 51 |
---|
| 89 | + | sequencing covered by this section must be used only to assist 52 |
---|
| 90 | + | the ordering health care professional and treating care team in 53 |
---|
| 91 | + | diagnosing and treating the patient. As protected health 54 |
---|
| 92 | + | information, this patient genetic data is subject to the privacy 55 |
---|
| 93 | + | provisions of the federal Health Insurance Portability and 56 |
---|
| 94 | + | Accountability Act of 1996 and its implementing regulations. 57 |
---|
| 95 | + | (b) Genetic data generated from rapid whole genome 58 |
---|
| 96 | + | sequencing covered under this section may be used in scientific 59 |
---|
| 97 | + | research if the patient, or the patient's legal guardian if the 60 |
---|
| 98 | + | patient is a minor, has given express consent for that use of 61 |
---|
| 99 | + | the data. A patient or patient's legal guardian, as applicable, 62 |
---|
| 100 | + | has the right to rescind the original consent to the use of the 63 |
---|
| 101 | + | data in scientific research at any time, and upon receipt of a 64 |
---|
| 102 | + | written revocation of the consent, the health care provider or 65 |
---|
| 103 | + | other entity using the data must cease its use of the data and 66 |
---|
| 104 | + | expunge the data from any data repository where it is held. 67 |
---|
| 105 | + | (4) The agency shall seek approval to amend current 68 |
---|
| 106 | + | waivers, request a new waiver, and amend contracts as necessary 69 |
---|
| 107 | + | to provide for coverage of services under this section. 70 |
---|
| 108 | + | (5) The agency shall adopt rules to implement this 71 |
---|
| 109 | + | section. 72 |
---|
| 110 | + | Section 2. This act shall take effect July 1, 2023. 73 |
---|